Načítá se...

Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes

BACKGROUND: Myasthenia is a condition in which neuromuscular transmission is affected by antibodies against neuromuscular junction components (autoimmune myasthenia gravis, MG; and neonatal myasthenia gravis, NMG) or by defects in genes for neuromuscular junction proteins (congenital myasthenic synd...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Vrinten, Charlotte, van der Zwaag, Angeli M, Weinreich, Stephanie S, Scholten, Rob JPM, Verschuuren, Jan JGM
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2014
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7387729/
https://ncbi.nlm.nih.gov/pubmed/25515947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010028.pub2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!